These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28377439)

  • 1. Association Between Use of Long-Acting Nitrates and Outcomes in Heart Failure With Preserved Ejection Fraction.
    Lim SL; Benson L; Dahlström U; Lam CS; Lund LH
    Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28377439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M; Friberg L
    JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M
    JAMA; 2012 Nov; 308(20):2108-17. PubMed ID: 23188027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry.
    Alehagen U; Benson L; Edner M; Dahlström U; Lund LH
    Circ Heart Fail; 2015 Mar; 8(2):252-60. PubMed ID: 25575580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Nitrates and Risk of Cardiovascular Events in Patients With Heart Failure With Preserved Ejection Fraction.
    Tsujimoto T; Kajio H
    Mayo Clin Proc; 2019 Jul; 94(7):1210-1220. PubMed ID: 31272569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Inorganic Nitrate Versus Placebo Treatment in Heart Failure with Preserved Ejection Fraction.
    Gui Y; Chen J; Hu J; Ouyang M; Deng L; Liu L; Sun K; Tang Y; Xiang Q; Xu J; Zhu L; Peng Z; Zou P; Li B; Zheng Z; Xu D
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):503-513. PubMed ID: 32394177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.
    Fu EL; Uijl A; Dekker FW; Lund LH; Savarese G; Carrero JJ
    Circ Heart Fail; 2020 Nov; 13(11):e007180. PubMed ID: 33070637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of spironolactone use with all-cause mortality in heart failure: a propensity scored cohort study.
    Lund LH; Svennblad B; Melhus H; Hallberg P; Dahlström U; Edner M
    Circ Heart Fail; 2013 Mar; 6(2):174-83. PubMed ID: 23386667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Effects of Statin Use on Mortality in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
    Lee MS; Duan L; Clare R; Hekimian A; Spencer H; Chen W
    Am J Cardiol; 2018 Aug; 122(3):405-412. PubMed ID: 30201108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Use of Statins and Mortality in Patients With Heart Failure and Ejection Fraction of ≥50.
    Alehagen U; Benson L; Edner M; Dahlström U; Lund LH
    Circ Heart Fail; 2015 Sep; 8(5):862-70. PubMed ID: 26243795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Oral Nitrates on All-Cause Mortality and Hospitalization in Heart Failure Patients with Reduced Ejection Fraction: A Propensity-Matched Analysis.
    Ural D; Kandemir AŞ; Karaüzüm K; Baydemir C; Karaüzüm İY; Bozyel S; Kozdağ G; Ağır AA
    J Card Fail; 2017 Apr; 23(4):286-292. PubMed ID: 28235568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of estimated plasma volume reduction on renal function for acute heart failure differs between patients with preserved and reduced ejection fraction.
    Takei M; Kohsaka S; Shiraishi Y; Goda A; Izumi Y; Yagawa M; Mizuno A; Sawano M; Inohara T; Kohno T; Fukuda K; Yoshikawa T;
    Circ Heart Fail; 2015 May; 8(3):527-32. PubMed ID: 25737498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and outcomes of HFpEF with declining ejection fraction.
    Park JJ; Park CS; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    Clin Res Cardiol; 2020 Feb; 109(2):225-234. PubMed ID: 31267239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a patient education programme in heart failure with preserved ejection fraction: Results from the ODIN cohort study using propensity score matching.
    Agrinier N; Schockmel M; Thilly N; Laborde-Castérot H; Jourdain P; Alla F; Leclercq C; Dany F; Druelle J; Drouet E; Mulak G; Juillière Y;
    Arch Cardiovasc Dis; 2018 Jan; 111(1):5-16. PubMed ID: 28943262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of treatment with carvedilol vs metoprolol succinate and mortality in patients with heart failure.
    Pasternak B; Svanström H; Melbye M; Hviid A
    JAMA Intern Med; 2014 Oct; 174(10):1597-604. PubMed ID: 25173681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction.
    Sandesara PB; Hammadah M; Samman-Tahhan A; Kelli HM; O'Neal WT
    Clin Cardiol; 2017 Sep; 40(9):692-696. PubMed ID: 28444995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 5-Year Outcomes After Coronary Artery Bypass Grafting in Heart Failure Patients With Versus Without Preserved Left Ventricular Ejection Fraction (from the CREDO-Kyoto CABG Registry Cohort-2).
    Marui A; Nishiwaki N; Komiya T; Hanyu M; Tanaka S; Kimura T; Sakata R;
    Am J Cardiol; 2015 Aug; 116(4):580-6. PubMed ID: 26092271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Lee SE; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Cho MC; Park HY; Oh BH
    Korean J Intern Med; 2019 Sep; 34(5):1030-1039. PubMed ID: 30317846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors.
    Philbin EF; Rocco TA; Lindenmuth NW; Ulrich K; Jenkins PL
    Am J Med; 2000 Dec; 109(8):605-13. PubMed ID: 11099679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.